Prescriptions plummeted during the pandemic: studyManitoba study shows sudden drop in all drug classes. Undiagnosed diabetes may be common in hospitalized COVID-19 patientsStudy suggests measuring HbA1c in COVID-19 patients. U.S. FDA approves first drug that can help prevent type 1 diabetes The biologic drug, monoclonal antibody teplizumab, is approved for people eight years old and older who are in stage 2 of type 1 diabetes. Why South Asians are at increased risk for diabetes: A complex interplay of genetics, diet and history In Canada, 14.4% of South Asians have Type 2 diabetes, the highest prevalence of any other ethnic group in the country. A simple approach to improving gestational diabetes management Study shows patients on simple insulin regimen experienced improvements in all primary measures. Could recent advances present a genuine 'cure' for type 1 diabetes? Highlights from the European Association for the Study of Diabetes congress in Stockholm. Two new biosimilar insulins now available in Canada Viatris is introducing Kirsty (insulin aspart) and Semglee (insulin glargine). New treatment approved for CKD associated with type 2 diabetes Health Canada approves adjunct treatment for chronic kidney disease based on two trial results. Low-carb vegan diet as effective as vegetarian approach for weight loss, glycemic control Vegetable oils and plant proteins beneficial for both type 2 diabetes and the planet. How income influences diabetes management Study shows income disparity linked to increased re-hospitalization rates. First Previous 10 11 12 13 14 Next Last
